3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
NET
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Tertiary Lymphoid Structures
1
Stomach Neoplasms
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Gastro-enteropancreatic neuroendocrine tumor
1
Esophageal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Adenocarcinoma
1
Interventions
Oxaliplatin
81
S 1 (combination)
55
Capecitabine
44
apatinib
32
Paclitaxel
32
Docetaxel
32
Irinotecan
27
Fluorouracil
22
Drug Therapy
21
sintilimab
20
Cisplatin
20
Leucovorin
16
Hyperthermic Intraperitoneal Chemotherapy
13
XELOX
12
Surgical Procedures, Operative
12
camrelizumab
10
Trastuzumab
10
titanium silicide
9
Tegafur
9
Nivolumab
9
Neoadjuvant Therapy
9
pembrolizumab
8
Laparoscopy
8
Gastrectomy
8
Folfox protocol
7
Chemotherapy, Adjuvant
7
toripalimab
6
tislelizumab
6
Ramucirumab
6
Gastroscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Stomach Neoplasms
×
Clinical Trials, Phase II as Topic
×
Clear all
NCT03475953
2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2
Unknown
747 enrolled